FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula I, as well as use thereof in the treatment or prevention of cancer or viral infection associated with LSD1.
I.
EFFECT: obtaining novel compounds (hetero)aryl cyclopropylamines having inhibitory activity of lysine-specific demethylase-1 (LSD1).
77 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2668952C2 |
| LYSIN-SPECIFIC DEMETHYLASE-1 INHIBITORS AND USE THEREOF | 2011 |
|
RU2599248C2 |
| LYSIN-SPECIFIC DEMETHYLASE-1 INHIBITORS AND USE THEREOF | 2010 |
|
RU2602814C2 |
| FLUORINATED COMPOUND OF CYCLOPROPYLAMINE, THE METHOD OF PREPARATION, THE PHARMACEUTICAL COMPOSITION AND ITS USE | 2017 |
|
RU2746323C2 |
| ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE | 2011 |
|
RU2611437C2 |
| AZOLINES | 2015 |
|
RU2727307C2 |
| STIMULATING AGENTS OF GROWTH HORMONE SECRETION | 1996 |
|
RU2172742C2 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
| METHODS FOR TREATMENT OF BEHAVIOR CHANGES | 2018 |
|
RU2799049C2 |
| N-(4-(AZAINDAZOL-6-IL)-PHENYL)-SULFONAMIDES AND THEIR USE AS DRUGS | 2014 |
|
RU2671864C2 |
